Identification of Undiagnosed Inflammatory Arthritis in a Community Health Fair Screen

Overview

Journal Arthritis Rheum

Specialty Rheumatology

Date 2009 Dec 2

PMID 19950306

Citations 23

Authors

Kevin D Deane

Christopher C Striebich

Barbara L Goldstein

Lezlie A Derber

Mark C Parish

Marie L Feser

Elaine M Hamburger

Stacey Brake

Cindy Belz

James Goddard

Jill M Norris

Elizabeth W Karlson

V Michael Holers

Affiliations

Soon will be listed here.

Abstract

Objective: To identify individuals with undiagnosed inflammatory arthritis (IA) and rheumatoid arthritis (RA) in a community health fair screen, and to establish in a health fair setting the diagnostic accuracy of combinations of the Connective Tissue Disease Screening Questionnaire (CSQ) and autoantibody testing for IA.

Methods: Screening for IA/RA was performed at health fair sites using a combination of the CSQ, joint examination, rheumatoid factor, and anti-cyclic citrullinated peptide (anti-CCP) antibody testing. IA was defined as > or =1 swollen joint suggestive of synovitis on joint examination by a trained clinician.

Results: Six hundred one subjects were screened; 51.0% participated because of joint symptoms (pain, stiffness, or swelling). Eighty-four subjects (14.0%) had > or =1 swollen joint, designated as IA on joint examination. Of the 601 subjects screened, 9 (1.5%) had IA and met > or =4 of 7 American College of Rheumatology criteria for RA but had no prior diagnosis of RA, and 15 (2.5%) had IA and RF and/or anti-CCP positivity, suggesting early RA. The diagnostic accuracy of combinations of the CSQ and autoantibody testing for the identification of IA yielded maximal sensitivity, specificity, and positive and negative predictive values of 95.3%, 99.2%, 71.4%, and 97.7%, respectively.

Conclusion: Health fair screening may be an effective approach for the identification of individuals with undiagnosed IA/RA. A combination of the CSQ and autoantibody testing alone has clinically useful diagnostic accuracy for the detection of IA. Decisions regarding which methodology to use for future health fair IA/RA screening will depend on goals of screening and funding.

Citing Articles

Barriers to the Diagnosis of Early Inflammatory Arthritis: A Literature Review.

Saraiva L, Duarte C Open Access Rheumatol. 2023; 15:11-22.

PMID: 36733437 PMC: 9888401. DOI: 10.2147/OARRR.S282622.

Associations of low handgrip strength and hand laterality with cognitive function and functional mobility - the Yishun Study.

Chen K, Lee S, Pang B, Lau L, Jabbar K, Seah W BMC Geriatr. 2022; 22(1):677.

PMID: 35974301 PMC: 9382769. DOI: 10.1186/s12877-022-03363-2.

Antibodies to Citrullinated Protein Antigens, Rheumatoid Factor Isotypes and the Shared Epitope and the Near-Term Development of Clinically-Apparent Rheumatoid Arthritis.

Bergstedt D, Tarter W, Peterson R, Feser M, Parish M, Striebich C Front Immunol. 2022; 13:916277.

PMID: 35812446 PMC: 9265214. DOI: 10.3389/fimmu.2022.916277.

Pre-RA: Can early diagnosis lead to prevention?.

Haville S, Deane K Best Pract Res Clin Rheumatol. 2022; 36(1):101737.

PMID: 34991984 PMC: 8977282. DOI: 10.1016/j.berh.2021.101737.

EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis.

Mankia K, Siddle H, Kerschbaumer A, Alpizar Rodriguez D, Catrina A, Canete J Ann Rheum Dis. 2021; 80(10):1286-1298.

PMID: 34362746 PMC: 8458095. DOI: 10.1136/annrheumdis-2021-220884.

References

Gabriel S . Why do people with rheumatoid arthritis still die prematurely?. Ann Rheum Dis. 2008; 67 Suppl 3:iii30-4. PMC: 2830861. DOI: 10.1136/ard.2008.098038. View

Sokka T, Abelson B, Pincus T . Mortality in rheumatoid arthritis: 2008 update. Clin Exp Rheumatol. 2008; 26(5 Suppl 51):S35-61. View

Valesini G, Di Franco M, Spinelli F, Scrivo R . Induction of remission in rheumatoid arthritis: criteria and opportunities. Rheumatol Int. 2008; 29(2):131-9. DOI: 10.1007/s00296-008-0699-0. View

Cush J . Early rheumatoid arthritis -- is there a window of opportunity?. J Rheumatol Suppl. 2007; 80:1-7. View

Cush J . Remodeling a rheumatology practice to facilitate early referral. Rheum Dis Clin North Am. 2005; 31(4):591-604. DOI: 10.1016/j.rdc.2005.07.005. View

Saraux A, Guillemin F, Fardellone P, Guggenbuhl P, Behier J, Cantagrel A . Agreement between rheumatologist visit and lay interviewer telephone survey for screening for rheumatoid arthritis and spondyloarthropathy. Joint Bone Spine. 2004; 71(1):44-50. DOI: 10.1016/S1297-319X(03)00092-7. View

Karlson E, Lee I, Cook N, Manson J, Buring J, Hennekens C . Comparison of self-reported diagnosis of connective tissue disease with medical records in female health professionals: the Women's Health Cohort Study. Am J Epidemiol. 1999; 150(6):652-60. DOI: 10.1093/oxfordjournals.aje.a010064. View

Potter J, Odutola J, Gonzales C, Ward M . Validation of English and Spanish-language versions of a screening questionnaire for rheumatoid arthritis in an underserved community. J Rheumatol. 2008; 35(8):1545-9. PMC: 2727680. View

Arnett F, Edworthy S, Bloch D, McShane D, Fries J, Cooper N . The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988; 31(3):315-24. DOI: 10.1002/art.1780310302. View

10.

Cush J . Early arthritis clinic: a USA perspective. Clin Exp Rheumatol. 2004; 21(5 Suppl 31):S75-8. View

11.

Huizinga T, Machold K, Breedveld F, Lipsky P, Smolen J . Criteria for early rheumatoid arthritis: from Bayes' law revisited to new thoughts on pathogenesis. Arthritis Rheum. 2002; 46(5):1155-9. DOI: 10.1002/art.10195. View

12.

Goekoop-Ruiterman Y, de Vries-Bouwstra J, Allaart C, van Zeben D, Kerstens P, Hazes J . Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trial. Arthritis Rheum. 2008; 58(2 Suppl):S126-35. DOI: 10.1002/art.23364. View

13.

Hwang A, Gupta S, Liang M . Identification of people with very early RA for optimal care: a public health challenge. Nat Clin Pract Rheumatol. 2008; 4(3):114-5. DOI: 10.1038/ncprheum0724. View

14.

Canaris G, Manowitz N, Mayor G, Ridgway E . The Colorado thyroid disease prevalence study. Arch Intern Med. 2000; 160(4):526-34. DOI: 10.1001/archinte.160.4.526. View

15.

Bejarano V, Quinn M, Conaghan P, Reece R, Keenan A, Walker D . Effect of the early use of the anti-tumor necrosis factor adalimumab on the prevention of job loss in patients with early rheumatoid arthritis. Arthritis Rheum. 2008; 59(10):1467-74. DOI: 10.1002/art.24106. View

16.

Cush J . Early arthritis clinics: if you build it will they come?. J Rheumatol. 2005; 32(2):203-7. View

17.

Liao K, Batra K, Chibnik L, Schur P, Costenbader K . Anti-cyclic citrullinated peptide revised criteria for the classification of rheumatoid arthritis. Ann Rheum Dis. 2008; 67(11):1557-61. PMC: 2964864. DOI: 10.1136/ard.2007.082339. View

18.

van Aken J, van Bilsen J, Allaart C, Huizinga T, Breedveld F . The Leiden Early Arthritis Clinic. Clin Exp Rheumatol. 2004; 21(5 Suppl 31):S100-5. View

19.

Guillemin F, Saraux A, Fardellone P, Guggenbuhl P, Behier J, Coste J . Detection of cases of inflammatory rheumatic disorders: performance of a telephone questionnaire designed for use by patient interviewers. Ann Rheum Dis. 2003; 62(10):957-63. PMC: 1754330. DOI: 10.1136/ard.62.10.957. View

20.

Helmick C, Felson D, Lawrence R, Gabriel S, Hirsch R, Kwoh C . Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum. 2008; 58(1):15-25. DOI: 10.1002/art.23177. View